No Record Found
Sector
PharmaceuticalsOpen
₹2,702.4Prev. Close
₹2,690.2Turnover(Lac.)
₹4,039.99Day's High
₹2,784.8Day's Low
₹2,702.452 Week's High
₹3,094.2552 Week's Low
₹2,327.3Book Value
₹330.55Face Value
₹2Mkt Cap (₹ Cr.)
34,107.43P/E
35.32EPS
76.07Divi. Yield
1.053 Nov 2025
12:00 AM
Dividend
Dividend Amount: 28
Record Date: 10 Nov, 2025
8 Oct 2025
12:00 AM
Board Meeting
Agenda : Audited Result
12 Jun 2025
12:00 AM
AGM
Announcement Date: 12 Jun, 2025
The company plans to launch the product after securing all necessary regulatory approvals, which are expected to be received between late 2026 and early 2027.
Ajanta Pharma reported a strong EBITDA margin of 25% in the quarter.
| Y/e 31 Mar( In .Cr) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
Equity Capital | 25.07 | 25.27 | 25.27 | 17.17 |
Preference Capital | 0 | 0 | 0 | 0 |
Reserves | 3,600.24 | 3,388.3 | 3,221.18 | 3,152.01 |
Net Worth | 3,625.31 | 3,413.57 | 3,246.45 | 3,169.18 |
Minority Interest |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Revenue | 3,140.64 | 2,718.59 | 2,196.42 | 1,825.35 |
yoy growth (%) | 15.52 | 23.77 | 20.32 | 1.16 |
Raw materials | -832.56 | -730.08 | -663.97 | -399.29 |
As % of sales | 26.5 | 26.85 | 30.22 | 21.87 |
Employee costs | -585.87 | -498.11 | -437.82 | -342.89 |
| Y/e 31 Mar( In .Cr) | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Profit before tax | 900.54 | 902.09 | 616.59 | 562.44 |
Depreciation | -120.96 | -111.49 | -91.29 | -57.14 |
Tax paid | -180.68 | -226.45 | -171.54 | -134.92 |
Working capital | 278.87 | 306.22 | 272.08 | 231.17 |
Other operating items |
| Y/e 31 Mar | Mar-2022 | Mar-2021 | Mar-2020 | Mar-2018 |
|---|---|---|---|---|
Growth matrix (%) | ||||
Revenue growth | 15.52 | 23.77 | 20.32 | 1.16 |
Op profit growth | -2.83 | 72.09 | -2.56 | -13.8 |
EBIT growth | 0.07 | 45.27 | 11.19 | -12.34 |
Net profit growth | 6.54 | 53.16 | 3.18 | -14.46 |
| Particulars (Rupees in Crores.) | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 | Mar-2021 |
|---|---|---|---|---|---|
Gross Sales | 4,648.1 | 4,208.71 | 3,742.64 | 3,340.99 | 2,889.69 |
Excise Duty | 0 | 0 | 0 | 0 | 0 |
Net Sales | 4,648.1 | 4,208.71 | 3,742.64 | 3,340.99 | 2,889.69 |
Other Operating Income | 0 | 0 | 0 | 0 | 0 |
Other Income | 94.5 | 84.6 | 98.64 | 115.68 | 25.98 |
Company Name | LTP (₹) | P/E (%) | Mkt.Cap (₹Cr.) | NP Qtr (₹Cr.) | Div.Yield (%) | Sales Qtr (₹.Cr) | Book Value (₹) |
|---|---|---|---|---|---|---|---|
Sun Pharmaceutical Industries Ltd SUNPHARMA | 1,717.2 | 88.17 | 4,12,085.78 | 564.22 | 0.93 | 4,511.27 | 99.24 |
Divis Laboratories Ltd DIVISLAB | 6,390.5 | 67.47 | 1,69,615.84 | 696 | 0.47 | 2,660 | 578.26 |
Torrent Pharmaceuticals Ltd TORNTPHARM | 3,793.7 | 60.14 | 1,28,360.51 | 597 | 0.16 | 2,707 | 249.82 |
Cipla Ltd CIPLA | 1,494 | 23.22 | 1,20,713.33 | 1,210.53 | 1.07 | 4,495.16 | 411.56 |
Dr Reddys Laboratories Ltd DRREDDY | 1,268.6 | 19.61 | 1,05,881.21 | 387.3 | 0.63 | 4,602.9 | 377.56 |
Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.
Chairman (Non-Executive)
Mannalal B Agrawal
Vice Chairman
Madhusudan B Agrawal
Managing Director
Yogesh Agrawal
Vice President & Company Secretary
Gaurang Shah
Joint Managing Director
Rajesh M Agrawal
Independent Director
David Rasquinha
Independent Director
Medha Joshi
Independent Director
Simi Thapar
Independent Director
Rajesh Shashikant Dalal
Ajanta House,
Charkop Kandivli (W),
Maharashtra - 400067
Tel: 91-22-66061000/1204/1203
Website: http://www.ajantapharma.com
Email: info@ajantapharma.com; investorgrievance@ajantapha
C-101 247 Park,
L B S Marg, Vikhroli West,
Mumbai-400083
Tel: 91-22-49186000
Website: https://in.mpms.mufg.com
Email: rnt.helpdesk@in.mpms.mufg.com
Summary
Ajanta Pharma Limited is a specialty pharmaceutical formulation company primarily with a well-diversified Branded Generics business spread across India, the Rest of Asia, and Africa. The Company is in...
Read More
Reports by Ajanta Pharma Ltd
What is the Ajanta Pharma Ltd share price today?
What is the Market Cap of Ajanta Pharma Ltd?
What is the PE and PB ratio of Ajanta Pharma Ltd?
What is the 52 Week High and Low of Ajanta Pharma Ltd?
What is the CAGR of Ajanta Pharma Ltd?
What is the shareholding pattern of Ajanta Pharma Ltd?
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
